BACKGROUND: More than half of patients hospitalized annually receive an opioid during their inpatient hospitalization, which may serve as a first opioid exposure. Although recent research addresses outpatient opioid prescribing following delivery, little is known regarding the extent to which opioids are used during the postpartum hospitalization following vaginal delivery. OBJECTIVE: Our objectives were as follows: (1) to describe the use of opioids during the last 24 hours of postpartum hospitalization in women following vaginal delivery and (2) to identify patient and provider characteristics associated with the use of opioids during this time period. STUDY DESIGN: This is a retrospective case-control study of women who underwent vaginal delivery at a single tertiary care center from Dec. 1, 2015, to Nov. 30, 2016. Inpatient, pharmacy, and administrative records were queried for clinical and inpatient prescriber data. Opioid use during the last 24 hours of the postpartum hospitalization was determined. Significant factors on bivariable analysis were assessed in multivariable hierarchical logistic regression with random effects to identify patient and provider factors associated with any opioid use. A subgroup analysis of women who underwent an uncomplicated vaginal delivery, defined as lack of intrapartum, postpartum, or neonatal complications, was performed. RESULTS: In this cohort of 9038 women after a vaginal delivery, almost a quarter (n ¼ 2242, 24.8%) utilized opioids during the last 24 hours of the postpartum hospitalization. In a multivariable analysis,
several patient characteristics were associated with increased odds of opioid use during the last 24 hours of admission, including higher body mass index, history of smoking and substance abuse, use of regional analgesia, vaginal birth after cesarean delivery, major laceration, postpartum hemorrhage, and infectious complication. Even after adjusting for these characteristics, greater use of acetaminophen (adjusted odds ratio, 0.81, 95% confidence interval, 0.77e0.85) and analgesia orders written by an advanced practitioner (adjusted odds ratio, 0.46, 95% confidence interval, 0.29e0.73) remained associated with decreased odds of using an opioid. The same 2 factors remained associated with less opioid use (acetaminophen doses [adjusted odds ratio, 0.86, 95% confidence interval, 0.81e0.92] and analgesia orders written by an advanced practitioner [adjusted odds ratio, 0.52, 95% confidence interval, 0.30e0.89]) when only women who had an uncomplicated vaginal delivery were analyzed. CONCLUSION: In a large cohort, nearly one-quarter of women use opioid analgesia during the last 24 hours of inpatient hospitalization following vaginal delivery. Although patient factors account for some of the variation in inpatient opioid use, both use of acetaminophen and having had postpartum orders written by an advanced practitioner were independently associated with lower odds of inpatient opioid use.
Key words: inpatient, opioid, postpartum, vaginal delivery O pioid misuse has been declared a national emergency by the US Government. 1 Data demonstrating that more than half of the 400 million patients hospitalized annually receive an opioid during their inpatient hospitalization 2 suggest that this high frequency of inpatient opioid use may serve as a first opioid exposure. Furthermore, inpatient opioid exposure can result in increased rates in inpatient complications and subsequent opioid abuse or dependence. 2 Therefore, further attention focused on inpatient opioid exposure is warranted.
The American Pain Society has published guidelines for the management of acute pain, 3 stressing that nonopioid analgesics, such as nonsteroidal antiinflammatory drugs (NSAIDs) and acetaminophen, should be used as first-line therapy, with the use of supplemental opioid medications only if needed. Nevertheless, despite the fact that labor and delivery is the most common reason for hospitalization in the United States, 4 relatively few data are available specifically to guide postdelivery pain management. Moreover, the literature that does exist largely focuses on outpatient prescribing and use of opioid analgesia following cesarean delivery, 5e7 with less information available regarding inpatient use of opioid analgesia following vaginal delivery.
One prospective study of about 150 postpartum women found that the majority of women did not require opioids for pain management following vaginal delivery; this finding suggests that the need for opioids, and particularly the need through the end of the typical postpartum stay, should be rare. 8 Thus, our objective was 2-fold: first, we aimed to describe the use of opioids during the last 24 hours of postpartum hospitalization in women following vaginal delivery, and second, we aimed to identify patient and provider characteristics associated with use of opioids during this time period. Additionally, because peripartum complications may be expected to increase analgesia need, we aimed to examine these questions specifically among women who experienced an uncomplicated vaginal delivery.
Materials and Methods
This is a retrospective case-control study of all opioid-naïve women who underwent a vaginal delivery at a single institution during a 1 year period (Dec. Exclusion criteria were as follows: documented evidence of recent opioid use, peripartum hysterectomy, admission to the intensive care unit, and postpartum stay exceeding 10 days. Recent opioid use was defined as either a diagnosis of opioid abuse, 3 or more prescriptions for an opioid in the year prior to delivery, or a prescription for buprenorphine, methadone, or fentanyl within a year of hospitalization. The remaining exclusion criteria were felt to represent rare events 9 that are expected to result in analgesic requirements beyond the typical range.
Demographic and clinical data were abstracted from outpatient and inpatient electronic medical records. International Classification of Diseases, ninth revision, and International Classification of Diseases, 10th revision, codes were used to corroborate the documented diagnoses of postpartum complications, substance abuse, and psychiatric comorbidities. Complications abstracted included postpartum hemorrhage (defined as estimated blood loss of greater than 500 mL), infectious complications (a composite of chorioamnionitis, endometritis, and wound infection), and major perineal laceration (defined third-or fourth-degree perineal lacerations).
At this institution, an obstetrical anesthesia team manages intrapartum pain, and the majority (more than 85%) of women undergoing vaginal delivery receive regional analgesia. Typically, postpartum pain is managed by the obstetrical team and analgesia orders are placed by one of the delivering providers. Orders are placed using an electronic ordering system using standardized postpartum order sets based on mode of delivery. During this time period, standard prescribing practices for inpatient analgesia following vaginal delivery includes ibuprofen 600 mg every 6 hours and acetaminophen 650 mg every 6 hours pro re nata.
Postpartum opioid orders are not part of the inpatient vaginal delivery order set; instead, they required a separate order. Opioids may be ordered as stand-alone medications (an opioid alone) or coformulated (an opioid-acetaminophen combination pill) at provider discretion. During the postpartum time period, analgesia orders are updated by the rounding provider as necessary.
Data regarding the prescribing provider were abstracted from administrative databases and included provider training (trainee, attending physician, advanced practitioner), age, and sex (male vs female). At this institution, patients receive inpatient care from advanced practitioners, including certified nurse midwives and nurse practitioners, attending physician providers, and/or trainee physicians depending on their provider group and their medical acuity.
For the purposes of this analysis, the prescribing provider was the person who wrote the order for the last opioid analgesia prescribed prior to hospital discharge. Also for the purposes of this analysis, the prescribing provider was the person who wrote the order for the analgesia medications available during the time frame of interest. During this study period, a total of 389 unique prescribing providers were identified; this included 169 attending physicians, 58 advanced practitioners (midwives and nurse practitioners), and 162 trainee physicians. Of the trainee physicians, 47 were obstetrics-gynecology residents or maternal-fetal medicine fellows and 115 were residents in nonobstetric residencies, including those in anesthesia, family medicine, and emergency medicine. The majority of the providers were female (274, 70.4%). The average age of the providers was 38.5 (AE10.0) years.
The primary outcome for this analysis was the use of any oral opioid taken during the last 24 hours of the inpatient admission following vaginal delivery. This time frame was chosen because it has been shown to be associated with opioid use following hospital discharge. 10 First, the proportion of women who received opioid analgesia within the time period of interest was quantified. Opioid analgesia type and strength used during the time period of interest was used to convert opioids to oral morphine milligram equivalents (MMEs). 11 Next, we performed bivariable comparisons to identify differences in patient and provider characteristics associated with the use of opioid during the last 24 hours of the inpatient hospitalization. Hierarchical multivariable logistic regression models accounting for clustering of patients at the provider level, with prescribing provider as a random effect, were utilized to identify patient and provider factors independently associated with the use of opioids until the end of hospital stay.
Models retained covariates with P < .05 on bivariable analysis. Postpartum AJOG at a Glance Why was this study constructed?
To describe the use of opioids during the last 24 hours of postpartum hospitalization after vaginal delivery.
To identify patient and provider characteristics associated with use of opioids after vaginal delivery.
Key Findings
Following a vaginal delivery, 24.8% of women utilized an opioid during the last 24 hours of postpartum hospitalization. Greater use of acetaminophen and having had orders written by an advanced practitioner were associated with a decreased likelihood of using an opioid.
What does this add to what is known?
Inpatient use of opioids is common in women undergoing vaginal deliveries, including among women who had uncomplicated deliveries. Even after accounting for patient factors associated with inpatient opioid use, greater use of acetaminophen and having had orders written by an advanced practitioner were significantly associated with decreased opioid use. 
FIGURE

Cohort flowsheet
This figure identifies the process for inclusion in the final analysis. Exclusions are not mutually exclusive.
ICU, intensive care unit; MME, morphine milligram equivalent; NSAID, nonsteroidal antiinflammatory drug. Original Research OBSTETRICS ajog.org depression), intrapartum complications (prior cesarean delivery, major perineal laceration, postpartum hemorrhage), or postpartum complications (infectious complication or a postpartum hospitalization exceeding the standard 2 days). The same analyses as described in previous text were performed in this subgroup.
Statistical analyses were performed with Stata version 15 (StataCorp, College Station, TX). This study was approved by the Institutional Review Board at Northwestern University.
Results
A total of 9038 women were included in analysis. The majority of women were non-Hispanic white (58.4%) and privately insured (51.7%). Approximately half (49.9%) were nulliparous. A little greater than half of the women (56.6%) had orders written by an attending physician, a third (30.9%) by a trainee physician, and 12.5% by an advanced practitioner. The majority of patients were cared for by a female provider (86.1%) ( Table 1) .
In this cohort, 24.8% (n ¼ 2242) used an opioid during the last 24 hours of inpatient hospitalization following delivery (Figure) . Women who used an opioid during this period used a median of 20 MMEs (equivalent to 4 tablets of hydrocodone 5 mg), although this use varied widely, ranging from 5 to 160 MMEs and 1 to 13 tablets. The use among women following an uncomplicated vaginal delivery was quite similar: the median also was 20 MMEs, with a range of 5e120 MMEs and 1e10 tablets ( Table 2 ). In addition, 25.8% and 97.1% of the patients used acetaminophen and NSAIDs in the last 24 hours of postpartum hospitalization, respectively. On bivariable analysis, women who used an opioid during the last 24 hours of their hospitalization were more likely to have a greater BMI, a history of smoking and substance abuse, and a history of depression and anxiety use. They were more likely to have utilized regional analgesia, have undergone a vaginal birth after cesarean delivery, and to have experienced a major perineal laceration, postpartum hemorrhage, and infectious complication (Table 3) . Furthermore, women who used an opioid were more likely to have orders written by a trainee physician (unadjusted odds ratio [OR] 1.36, 95% confidence interval [CI] 1.23e1.51).
Women who were of Asian race/ ethnicity used a greater number of NSAIDs (OR, 0.92, 95% CI, 0.87e0.96) and acetaminophen doses (OR, 0.81, 95% CI, 0.78e0.84) and had orders written by an advanced practitioner (OR, 0.70, 95% CI, 0.60e0.83) had lower odds of opioid use (Table 3) . In a multivariable analysis, many patient characteristics remained significantly associated with greater odds of opioid use (Table 3) .
After adjusting for these characteristics, a greater number of acetaminophen doses (adjusted odds ratio, 0.81, 95% CI, 0.77e0.85) and orders written by an advanced practitioner (adjusted odds ratio, 0.46, 95% CI, 0.29e0.73) remained associated with decreased odds of using an opioid.
Of the 5038 women who experienced an uncomplicated vaginal delivery (55.8% of the total cohort), 20.5% (n ¼ 1032) utilized an opioid in the final 24 hours of their postpartum hospitalization (Figure) . In this subgroup, 24.9% and 97.5% of women used acetaminophen and NSAIDs, respectively (Table 2) .
On bivariable analyses, higher BMI and intrapartum regional analgesia were associated with an increased odds of opioid use during the last 24 hours of postpartum hospitalization. Being married or of Asian race/ethnicity, using a greater number of doses of NSAIDs and acetaminophen, and having orders written by an advanced practitioner were associated with decreased odds of inpatient opioid use (Table 4) . In a multivariable analysis, each of these factors remained associated with odds of opioid use following uncomplicated vaginal delivery with the exception of number of NSAID doses (Table 4) .
Comment
Prior research has shown that more than half of all patients hospitalized for nonsurgical reasons receive Data are provided as mean (AESD), n (percentage), or median (interquartile range). aOR refers to the multivariable logistic regression accounting for covariates with P < .05 on a bivariable analysis and for clustering by provider; OR in referent to no inpatient opioid use.
aOR, adjusted odds ratio; BMI, body mass index; CI, confidence interval; LOS, length of stay; MME, morphine milligram equivalents; NSAID, nonsteroidal antiinflammatory drug; OR, odds ratio; VBAC, vaginal birth after cesarean delivery. 12 Several studies of women following cesarean delivery support the use of these first-line agents to reduce the amount of opioid consumed and decrease opioid related side effects. For example, one retrospective cohort study of 240 women after cesarean delivery compared opioid use in women who had received scheduled acetaminophen with opioids pro re nata with those receiving combination acetaminophen-opioids pre re nata. 13 Women in the scheduled acetaminophen group used significantly fewer opioids and had similar pain scores as those receiving acetaminophen-opioids pro re nata. 13 Similarly, in our large cohort of greater than 9000 women following vaginal delivery, we found that greater acetaminophen use was significantly associated with a decreased likelihood of opioid use during the last 24 hours of inpatient hospitalization, and this was true even if delivery was uncomplicated.
It has been reported that the variability in inpatient opioid use between hospitals and regions is not fully accounted for by patient-specific clinical factors. 2 Our Data are provided as mean (AESD), n (percentage), or median (interquartile range). aOR refers to the multivariable logistic regression accounting for covariates with P < .05 on a bivariable analysis and for clustering by provider; OR is referent to no inpatient opioid use.
aOR, adjusted odds ratio; BMI, body mass index; CI, confidence interval; LOS, length of stay; MME, morphine milligram equivalents; NSAID, nonsteroidal antiinflammatory drug; OR, odds ratio. These results may be partially explained by the midwifery model of care, which is thought to support the pregnancy and childbirth process as a normal and nonmedical event. 14, 15 Therefore, these caregivers are often trained to encourage low-intervention methods of pain management, and the women who choose such providers may also be more inclined to opt for less medicalized care. For example, the use of regional analgesia is lower in patients cared for by nonobstetrician delivery providers, 16 and surveys of midwives have shown less favorable attitudes toward regional analgesia. 15, 17 Furthermore, a Cochrane review in 2013 further found that women cared for by midwives were less likely to receive pain medication in labor than those cared for by physicians. Our data support this association.
Our study has several strengths. Primarily, this study is unique in its provider-level data. A unified electronic medical and pharmacy record allowed for collection of detailed patient data. Additionally, the large sample size and diverse patient and provider population allows for increased generalizability.
This study also has several limitations. This is a retrospective study and is therefore susceptible to incomplete data and misclassification. The study was limited to a single institution, and care models, standard postpartum analgesia management, and culture may vary in other settings. Finally, we are unable to fully account for potential confounders that may influence selection of provider types. In addition, the provider who wrote the postpartum analgesia orders may be a different individual from the provider who rounded on the patient during the last 24 hours of admission, and we are unable to account for any bias that this may introduce.
In summary, we examined opioid use following vaginal delivery in a large postpartum cohort and identified that nearly 1 in 4 women use opioid analgesia during the last 24 hours of inpatient hospitalization following vaginal delivery. Notably, 1 in 5 women who experienced an uncomplicated vaginal delivery used opioid analgesia in this time frame. Although patient factors account for some variation in inpatient opioid use, both the use of acetaminophen and the orders written by an advanced practitioner were independently associated with lower odds of inpatient opioid use. These data suggest that different approaches to postpartum pain management may promote a lesser use of inpatient opioids throughout the postpartum admission. n
